Download Citation
Article Source:
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
Tarcha EJ,
Olsen CM,
Probst P,
Peckham D,
Muñoz-Elías EJ,
et al.
(2017)
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial.
PLOS ONE 12(7): e0180762.
https://doi.org/10.1371/journal.pone.0180762